Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by...
FDA Drug Recall #D-1409-2014 — Class II — April 16, 2014
Recall Summary
| Recall Number | D-1409-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 16, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Pfizer Us Pharmaceutical Group |
| Location | New York, NY |
| Product Type | Drugs |
| Quantity | 220,761 bottles |
Product Description
Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30
Reason for Recall
Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.
Distribution Pattern
Nationwide
Lot / Code Information
H74477, H74478, Exp. 03/16, H74479, H79766 Exp. 05/16
Other Recalls from Pfizer Us Pharmaceutical Group
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1328-2014 | Class I | Effexor XR (venlafaxine HCl) Extended-Release C... | Mar 6, 2014 |
| D-1166-2014 | Class III | Advil PM Caplets, (Ibuprofen, 200 mg /Diphenhyd... | Feb 26, 2014 |
| D-014-2014 | Class II | Aldactone (spironolactone) tablets, USP, 100 mg... | Sep 4, 2013 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.